Company / SG&A per Share
PUMA BIOTECHNOLOGY, INC. SG&A per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.83
FY2025
5-year range
$1.83 / $3.53
FY2021-FY2025
Trend
-3.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has declined for 5 consecutive years, from $3.73 in FY2020 to $1.83 in FY2025.
Based on SEC 10-K filings.
1.83 in FY2025 with a 5-year CAGR of -13.3%.
Improved from $2.51 to $1.83 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -14.0%
- 5-Year CAGR
- -13.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- PUMA BIOTECHNOLOGY, INC.'s sg&a per share has declined for 5 consecutive years.
- In FY2025, sg&a per share decreased 3.0% year-over-year.
- Peak sg&a per share was recorded in FY2020.
- Lowest sg&a per share in the period was in FY2017.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.83 | -3.0% |
| FY2024 | $1.89 | -24.7% |
| FY2023 | $2.51 | -12.8% |
| FY2022 | $2.88 | -18.6% |
| FY2021 | $3.53 | -5.2% |
| FY2020 | $3.73 | +33.9% |
| FY2019 | $2.78 | +94.5% |
| FY2018 | $1.43 | +65.7% |
| FY2017 | $0.86 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026